{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:34:42Z","timestamp":1792784082371,"version":"4.5.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Mrs Hsiu-Chin Lee Lin Kidney Research Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","jfma-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.jfma.2014.11.002","type":"journal-article","created":{"date-parts":[[2015,1,2]],"date-time":"2015-01-02T09:01:53Z","timestamp":1420189313000},"page":"102-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Membranous nephropathy: A review on the pathogenesis, diagnosis, and treatment"],"prefix":"10.1016","volume":"114","author":[{"given":"Wei Ling","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting Hao","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh Kai","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8844-0988","authenticated-orcid":false,"given":"Wen Chih","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan Dun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tun Jun","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2014.11.002_bib1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0270-9295(03)00049-4","article-title":"Diagnosis and natural course of membranous nephropathy","volume":"23","author":"Glassock","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ndt\/12.3.418","article-title":"Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. The Italian Group of Renal Immunopathology","volume":"12","author":"Schena","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jfma.2014.11.002_bib3","first-page":"340","article-title":"Renal Immunopathology Study Group of the Italian Society of Nephrology. Epidemiology of primary glomerulonephritis in the elderly. Report from the Italian Registry of Renal Biopsy","volume":"14","author":"Vendemia","year":"2001","journal-title":"J Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/ndt\/gfi207","article-title":"Epidemiology of renal disease in Romania: a 10 year review of two regional renal biopsy databases","volume":"21","author":"Covic","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jfma.2014.11.002_bib5","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1093\/ndt\/gfh521","article-title":"The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994\u20132000","volume":"19","author":"Rychl\u00edk","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jfma.2014.11.002_bib6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0272-6386(95)90568-5","article-title":"A review of therapeutic studies of idiopathic membranous glomerulopathy","volume":"25","author":"Hogan","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2014.11.002_bib7","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/jcp.39.11.1193","article-title":"Idiopathic membranous glomerulonephritis: aspects of geographical differences","volume":"39","author":"Abe","year":"1986","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jfma.2014.11.002_bib8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.ajkd.2007.06.003","article-title":"Long-term risk of cancer in membranous nephropathy patients","volume":"50","author":"Bj\u00f8rneklett","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2014.11.002_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00281-003-0119-1","article-title":"The role of antibodies and B cells in the pathogenesis of lupus nephritis","volume":"24","author":"Shlomchik","year":"2003","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.jfma.2014.11.002_bib10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1084\/jem.149.5.1099","article-title":"Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus","volume":"149","author":"Izui","year":"1979","journal-title":"J Exp Med"},{"key":"10.1016\/j.jfma.2014.11.002_bib11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.126.4.607","article-title":"Immunological studies concerning the nephritis of systemic lupus erythematosus","volume":"126","author":"Koffler","year":"1967","journal-title":"J Exp Med"},{"key":"10.1016\/j.jfma.2014.11.002_bib12","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM199105233242103","article-title":"Membranous nephropathy related to hepatitis B virus in adults","volume":"324","author":"Lai","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2014.11.002_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/modpathol.3880031","article-title":"Hepatitis B virus-related nephropathy and lupus nephritis: morphologic similarities of two clinical entities","volume":"13","author":"Lai","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jfma.2014.11.002_bib14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000077065","article-title":"Hepatitis B virus-associated nephropathy","volume":"24","author":"Bhimma","year":"2004","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0272-6386(12)70152-X","article-title":"Membranous glomerulonephritis in association with hepatitis C virus infection","volume":"22","author":"Davda","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2014.11.002_bib16","doi-asserted-by":"crossref","first-page":"c121","DOI":"10.1159\/000325220","article-title":"Treatment of hepatitis C-mediated glomerular disease","volume":"119","author":"Sandri","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jfma.2014.11.002_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000333772","article-title":"Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapy","volume":"176","author":"Morales","year":"2012","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s004280050094","article-title":"Helicobacter pylori antigen in the glomeruli of patients with membranous nephropathy","volume":"431","author":"Nagashima","year":"1997","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jfma.2014.11.002_bib19","doi-asserted-by":"crossref","first-page":"180690","DOI":"10.1155\/2014\/180690","article-title":"The effects of Helicobacter pylori eradication on proteinuria in patients with primary glomerulonephritis","volume":"2014","author":"Caliskan","year":"2014","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0272-6386(12)70160-9","article-title":"Membranous glomerulonephritis and malignancy","volume":"22","author":"Burstein","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2014.11.002_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.semnephrol.2010.09.011","article-title":"Membranous nephropathy and malignancy","volume":"30","author":"Beck","year":"2010","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrneph.2010.171","article-title":"Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis","volume":"7","author":"Lien","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib23","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2215\/CJN.03770412","article-title":"Onco-nephrology: glomerular diseases with cancer","volume":"7","author":"Cambier","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ki.2012.484","article-title":"Glomerular diseases seen with cancer and chemotherapy: a narrative review","volume":"84","author":"Jhaveri","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2014.11.002_bib25","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1056\/NEJM198105143042006","article-title":"Studies of immune-complex glomerulonephritis mediated by human thyroglobulin","volume":"304","author":"Jordan","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2014.11.002_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2169\/internalmedicine1962.21.29","article-title":"A case of membranous nephropathy associated with thyroid antigens","volume":"21","author":"Iwaoka","year":"1982","journal-title":"Jpn J Med"},{"key":"10.1016\/j.jfma.2014.11.002_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00467-008-1009-5","article-title":"Pathophysiological lessons from rare associations of immunological disorders","volume":"24","author":"Ronco","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00467-008-0973-0","article-title":"Membranous nephropathy associated with thyroid-peroxidase antigen","volume":"24","author":"Shima","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib29","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1056\/NEJMoa1013792","article-title":"Early-childhood membranous nephropathy due to cationic bovine serum albumin","volume":"364","author":"Debiec","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2014.11.002_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00041552-199905000-00005","article-title":"Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis","volume":"8","author":"Berden","year":"1999","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jfma.2014.11.002_bib31","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3181\/00379727-100-24736","article-title":"Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions","volume":"100","author":"Heymann","year":"1959","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.jfma.2014.11.002_bib32","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1172\/JCI109248","article-title":"Experimental glomerulonephritis in the isolated perfused rat kidney","volume":"62","author":"Couser","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jfma.2014.11.002_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1681\/ASN.V6135","article-title":"The Heymann nephritis antigenic complex: megalin (gp330) and RAP","volume":"6","author":"Farquhar","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib34","doi-asserted-by":"crossref","first-page":"e25065","DOI":"10.1371\/journal.pone.0025065","article-title":"Receptor-mediated endocytosis of \u03b1-galactosidase A in human podocytes in Fabry disease","volume":"6","author":"Prabakaran","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jfma.2014.11.002_bib35","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1681\/ASN.2005101144","article-title":"Nested N-terminal megalin fragments induce high-titer autoantibody and attenuated Heymann nephritis","volume":"17","author":"Tramontano","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib36","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMoa012895","article-title":"Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies","volume":"346","author":"Debiec","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2014.11.002_bib37","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(04)17142-0","article-title":"Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies","volume":"364","author":"Debiec","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2014.11.002_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2014.11.002_bib39","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"Qin","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ki.2012.209","article-title":"Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy","volume":"82","author":"Hoxha","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2014.11.002_bib41","first-page":"109","article-title":"Anti-PLA2R antibodies in membranous nephropathy: ready for routine clinical practice?","volume":"70","author":"Hofstra","year":"2012","journal-title":"Neth J Med"},{"key":"10.1016\/j.jfma.2014.11.002_bib42","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2215\/CJN.07210810","article-title":"Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy","volume":"6","author":"Hofstra","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib43","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2012030242","article-title":"Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy","volume":"23","author":"Hofstra","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib44","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2249.1999.01080.x","article-title":"Circulating antibodies against alpha-enolase in patients with primary membranous nephropathy (MN)","volume":"118","author":"Wakui","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jfma.2014.11.002_bib45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2008121259","article-title":"Autoimmunity in membranous nephropathy targets aldose reductase and SOD2","volume":"21","author":"Prunotto","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib46","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2215\/CJN.02170312","article-title":"Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy","volume":"7","author":"Murtas","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib47","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1009742","article-title":"Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy","volume":"364","author":"Stanescu","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2014.11.002_bib48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2215\/CJN.05310513","article-title":"HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy","volume":"9","author":"Bullich","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib49","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1681\/ASN.2012080771","article-title":"Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy","volume":"24","author":"Lv","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000090706","article-title":"Tumor necrosis factor-alpha gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis","volume":"26","author":"Bantis","year":"2006","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib51","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.ki.5002054","article-title":"TNFA2 and d2 alleles of the tumor necrosis factor alpha gene polymorphism are associated with onset\/occurrence of idiopathic membranous nephropathy","volume":"71","author":"Thibaudin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2014.11.002_bib52","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cca.2010.02.004","article-title":"Association between genetic polymorphisms of the NPHS1 gene and membranous glomerulonephritis in the Taiwanese population","volume":"411","author":"Lo","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jfma.2014.11.002_bib53","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1093\/ndt\/gfn258","article-title":"Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy","volume":"23","author":"Chen","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jfma.2014.11.002_bib54","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3892\/mmr.2014.1903","article-title":"Impact of the 4G\/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome","volume":"9","author":"Luo","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jfma.2014.11.002_bib55","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3109\/0886022X.2010.516857","article-title":"Effect of IL-6 C-572G polymorphism on idiopathic membranous nephropathy risk in a Han Chinese population","volume":"32","author":"Chen","year":"2010","journal-title":"Ren Fail"},{"key":"10.1016\/j.jfma.2014.11.002_bib56","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.cca.2011.06.020","article-title":"Association of STAT4 polymorphisms with susceptibility to primary membranous glomerulonephritis and renal failure","volume":"412","author":"Chen","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jfma.2014.11.002_bib57","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3109\/0886022X.2013.828264","article-title":"Toll-like receptor 9 SNPs are susceptible to the development and progression of membranous glomerulonephritis: 27 years follow-up in Taiwan","volume":"35","author":"Chen","year":"2013","journal-title":"Ren Fail"},{"key":"10.1016\/j.jfma.2014.11.002_bib58","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.4049\/jimmunol.137.5.1511","article-title":"The membrane attack complex in complement-mediated glomerular epithelial cell injury: formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy","volume":"137","author":"Cybulsky","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.jfma.2014.11.002_bib59","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1172\/JCI112408","article-title":"Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy","volume":"77","author":"Cybulsky","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jfma.2014.11.002_bib60","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1172\/JCI111159","article-title":"Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit","volume":"72","author":"Groggel","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jfma.2014.11.002_bib61","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI109987","article-title":"A new role for complement in experimental membranous nephropathy in rats","volume":"66","author":"Salant","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jfma.2014.11.002_bib62","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1084\/jem.157.6.1885","article-title":"Localization of the membrane attack complex (MAC) in experimental immune complex glomerulonephritis","volume":"157","author":"Koffler","year":"1983","journal-title":"J Exp Med"},{"key":"10.1016\/j.jfma.2014.11.002_bib63","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2014.11.002_bib64","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1172\/JCI112372","article-title":"Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells","volume":"77","author":"Adler","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jfma.2014.11.002_bib65","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1073\/pnas.90.8.3645","article-title":"Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis","volume":"90","author":"Neale","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jfma.2014.11.002_bib66","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/ki.1990.91","article-title":"C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells","volume":"37","author":"Torbohm","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2014.11.002_bib67","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1172\/JCI118502","article-title":"Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy","volume":"97","author":"McMillan","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jfma.2014.11.002_bib68","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1046\/j.1523-1755.2003.00305.x","article-title":"Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy","volume":"64","author":"Saran","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2014.11.002_bib69","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1046\/j.1523-1755.1999.00407.x","article-title":"Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions","volume":"55","author":"Topham","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2014.11.002_bib70","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1681\/ASN.V134946","article-title":"Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy","volume":"13","author":"Yuan","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib71","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI200112367","article-title":"Apoptosis in podocytes induced by TGF-beta and Smad7","volume":"108","author":"Schiffer","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jfma.2014.11.002_bib72","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1046\/j.1523-1755.2003.00217.x","article-title":"Podocytes that detach in experimental membranous nephropathy are viable","volume":"64","author":"Petermann","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2014.11.002_bib73","first-page":"57","article-title":"Distribution of IgG subclasses in membranous nephropathy","volume":"58","author":"Doi","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jfma.2014.11.002_bib74","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00467-009-1439-8","article-title":"IgG subclasses and complement pathway in segmental and global membranous nephropathy","volume":"25","author":"Segawa","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib75","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1746-1596-7-109","article-title":"The continual presence of C3d but not IgG glomerular capillary deposition in stage I idiopathic membranous nephropathy in patients receiving corticosteroid treatment","volume":"7","author":"Zhang","year":"2012","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jfma.2014.11.002_bib76","first-page":"295","article-title":"C4d as a diagnostic tool in membranous nephropathy","volume":"32","author":"Espinosa-Hern\u00e1ndez","year":"2012","journal-title":"Nefrologia"},{"key":"10.1016\/j.jfma.2014.11.002_bib77","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000183255","article-title":"Demonstration of C3d deposits in membranous nephropathy","volume":"37","author":"Doi","year":"1984","journal-title":"Nephron"},{"key":"10.1016\/j.jfma.2014.11.002_bib78","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000185234","article-title":"Glomerular deposition of C4 cleavage fragment (C4d) and C4-binding protein in idiopathic membranous glomerulonephritis","volume":"51","author":"Kusunoki","year":"1989","journal-title":"Nephron"},{"key":"10.1016\/j.jfma.2014.11.002_bib79","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.167.5.2861","article-title":"Human IgA activates the complement system via the mannan-binding lectin pathway","volume":"167","author":"Roos","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jfma.2014.11.002_bib80","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/modpathol.2012.237","article-title":"IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression","volume":"26","author":"Huang","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jfma.2014.11.002_bib81","series-title":"Heptinstall's pathology of the kidney","first-page":"205","article-title":"Membranous glomerulonephritis","author":"Schwartz","year":"2007"},{"key":"10.1016\/j.jfma.2014.11.002_bib82","first-page":"443","article-title":"Membranous nephropathy","volume":"1","author":"Churg","year":"1973","journal-title":"Perspect Nephrol Hypertens"},{"key":"10.1016\/j.jfma.2014.11.002_bib83","series-title":"Brenner and Rector's the kidney","first-page":"1100","article-title":"Primary glomerular disease","author":"Nachman","year":"2012"},{"key":"10.1016\/j.jfma.2014.11.002_bib84","first-page":"186","article-title":"KDIGO clinical practice guideline for glomerulonephritis","volume":"2","author":"KDIGO Glomerulonephritis Work Group","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2014.11.002_bib85","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0272-6386(12)80997-8","article-title":"IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies","volume":"23","author":"Haas","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2014.11.002_bib86","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ndt\/gfg616","article-title":"Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy","volume":"19","author":"Ohtani","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jfma.2014.11.002_bib87","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/modpathol.2012.207","article-title":"Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies","volume":"26","author":"Larsen","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jfma.2014.11.002_bib88","first-page":"649","article-title":"Membranous nephropathy","volume":"77","author":"Sherman","year":"1980","journal-title":"J Med Soc N J"},{"key":"10.1016\/j.jfma.2014.11.002_bib89","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0002-9343(79)90486-8","article-title":"Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients","volume":"66","author":"Noel","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.jfma.2014.11.002_bib90","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1681\/ASN.2009080861","article-title":"Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy","volume":"21","author":"Polanco","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib91","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"Kanigicherla","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2014.11.002_bib92","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ki.1997.127","article-title":"Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications","volume":"51","author":"Cattran","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2014.11.002_bib93","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1681\/ASN.2004040287","article-title":"Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study","volume":"16","author":"Branten","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib94","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1093\/ndt\/gfn007","article-title":"Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy","volume":"23","author":"Hofstra","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jfma.2014.11.002_bib95","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.2215\/CJN.00670112","article-title":"Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy","volume":"7","author":"van den Brand","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib96","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013040430","article-title":"Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy","volume":"25","author":"Hoxha","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib97","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1681\/ASN.2012010058","article-title":"Treatment of idiopathic membranous nephropathy","volume":"23","author":"Waldman","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib98","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1523-1755.2004.00518.x","article-title":"Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan","volume":"65","author":"Shiiki","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2014.11.002_bib99","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1681\/ASN.V93444","article-title":"A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy","volume":"9","author":"Ponticelli","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM198901053200102","article-title":"A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy","volume":"320","author":"Ponticelli","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2014.11.002_bib101","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/ki.1995.453","article-title":"A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy","volume":"48","author":"Ponticelli","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2014.11.002_bib102","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1681\/ASN.2013020185","article-title":"Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategy","volume":"25","author":"van den Brand","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib103","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1046\/j.1523-1755.2001.0590041484.x","article-title":"Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial","volume":"59","author":"Cattran","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2014.11.002_bib104","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.biopha.2010.10.009","article-title":"Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: a 3-year prospective study","volume":"65","author":"Naumovic","year":"2011","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jfma.2014.11.002_bib105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MAJ.0b013e3181ca3a7d","article-title":"Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial","volume":"339","author":"Chen","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jfma.2014.11.002_bib106","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.ki.5002215","article-title":"Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial","volume":"71","author":"Praga","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2014.11.002_bib107","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000167436","article-title":"Treatment of idiopathic membranous nephropathy unresponsive to methylprednisolone and chlorambucil with cyclosporin","volume":"7","author":"DeSanto","year":"1987","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib108","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ndt\/14.4.1036","article-title":"Treatment of membranous glomerulopathy with cyclosporin A: how much patience is required?","volume":"14","author":"Fritsche","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jfma.2014.11.002_bib109","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(12)61566-9","article-title":"Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial","volume":"381","author":"Howman","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2014.11.002_bib110","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.2215\/CJN.05080610","article-title":"Rituximab therapy in idiopathic membranous nephropathy: a 2-year study","volume":"5","author":"Fervenza","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2014.11.002_bib111","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.ajkd.2007.05.015","article-title":"Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide","volume":"50","author":"Branten","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2014.11.002_bib112","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1440-1797.2007.00822.x","article-title":"Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome","volume":"12","author":"Chan","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.jfma.2014.11.002_bib113","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1053\/j.ajkd.2008.04.013","article-title":"Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial","volume":"52","author":"Dussol","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2014.11.002_bib114","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/ndt\/gfu069","article-title":"A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar\u00ae Gel) in nephrotic syndrome due to idiopathic membranous nephropathy","volume":"29","author":"Hladunewich","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jfma.2014.11.002_bib115","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/j.ajkd.2008.05.012","article-title":"Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial","volume":"52","author":"Lin","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2014.11.002_bib116","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/sj.ki.5000302","article-title":"Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases","volume":"69","author":"Chen","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2014.11.002_bib117","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jfma.2014.01.002","article-title":"Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease","volume":"113","author":"Chen","year":"2014","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2014.11.002_bib118","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40261-013-0057-1","article-title":"Effect of add-on pentoxifylline on proteinuria in membranous glomerulonephritis: a 6-month placebo-controlled trial","volume":"33","author":"Badri","year":"2013","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jfma.2014.11.002_bib119","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/ard.59.11.841","article-title":"Leflunomide: mode of action in the treatment of rheumatoid arthritis","volume":"59","author":"Breedveld","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jfma.2014.11.002_bib120","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/nep.12143","article-title":"Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety","volume":"18","author":"Yang","year":"2013","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.jfma.2014.11.002_bib121","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1053\/j.ajkd.2007.07.032","article-title":"Treatment of idiopathic membranous nephropathy with the herb Astragalus membranaceus","volume":"50","author":"Ahmed","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2014.11.002_bib122","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1053\/j.ajkd.2010.01.012","article-title":"Remission of membranous nephropathy after therapy with Astragalus membranaceus","volume":"55","author":"Leehey","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2014.11.002_bib123","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.ajkd.2013.05.005","article-title":"Efficacy and safety of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial","volume":"62","author":"Chen","year":"2013","journal-title":"Am J Kidney Dis"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664614002952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664614002952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T05:03:09Z","timestamp":1690779789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664614002952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":123,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0929664614002952"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2014.11.002","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Membranous nephropathy: A review on the pathogenesis, diagnosis, and treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2014.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier (Singapore) Pte Ltd.","name":"copyright","label":"Copyright"}]}}